Herbal medicines can have many medicinal interactions with other drugs, including those that have already been approved.
Some of these interactions have already happened in human trials.
In the past week alone, herbal medicines have been shown to affect the function of several cancers, including breast cancer, lung cancer, prostate cancer and colorectal cancer.
One of the most common interactions that herbal medicines can cause with cancer drugs is a decrease in the activity of a protein called the cancer cell killer, known as the CCR5 gene.
The CCR10 gene is one of the three main proteins that regulate how cancer cells develop.
The effect of herbal medicines on cancer cells is still unclear, but research has shown that some herbal medicines inhibit CCR7, a gene that is linked to the development of breast cancer and other cancers.
The CCR4 gene is also associated with breast cancer development.
Another potential interaction with herbal medicines is that they can increase the levels of a molecule called a tumor necrosis factor (TNF) that is a cancer-fighting protein.
The levels of this protein are linked to how well the immune system responds to TNF.
A third possible interaction involves a decrease of the activity or activity of the enzyme, chemokine, that helps tumors kill cells.
The interactions between herbal medicines and cancer drugs are often linked to other treatments, including the use of chemotherapy.
There are currently two herbal medicines that have been tested in human studies for the interaction between cancer drugs and herbal medicines.
One is called Cimicin, which has been tested for cancer-related symptoms such as nausea, vomiting, diarrhea and headache.
The other is Nifedipine, which is used to treat a rare form of liver cancer.
The two herbal products have been approved by the Food and Drug Administration.
“The use of these herbal medicines for cancer patients is an important option for patients in need,” Dr Mihaly Sipa, the chief scientific officer for the Cancer Council, said in a statement.
“With the advent of new and more efficient cancer therapies, it is now essential to develop new therapies for cancer to avoid any side effects,” he said.
“While it is not known exactly how the interactions between these two herbs affect the human body, we believe it could be related to their interaction with the cancer drugs,” Dr Sipal said.
Dr Sipan said the herbal medicines could potentially improve the cancer-causing properties of the cancer drug, but there was no evidence to support that.
“There is no evidence of a relationship between cancer treatment and the herbal medicine interactions, but the fact that the two herbs are used together may be a potential advantage,” he added.
The Cancer Council recommends that people avoid using any herbal medicines during pregnancy or breastfeeding, and that patients who are pregnant or breast-feeding should use other therapies to control their cancer.
“We believe it is important to take a careful look at herbal medicines to make sure they are safe and effective when used for their intended purpose,” Dr Aida Fauzia, the executive director of the Cancer Prevention and Control Research Institute (CPRI), said in the statement.
Dr Mihali Sipah, the medical director of CPRI, said it was not uncommon for herbal medicines in the market to interact with cancer medicines.
“This may be because some herbal medicine are in different doses and are also in different forms,” he explained.
“In this case, the amount of the interaction could be greater than that between the two cancer drugs.”
The CPTI said the most likely reason for the interactions is the herbal products being used together in a single treatment.
“It is not possible to say for certain that there is a direct relationship between the herbal product and the drug,” it said.
“However, it would be premature to dismiss such interactions out of hand.”
If the patient is experiencing symptoms of cancer, then it is a good idea to consult a physician for further diagnosis and treatment.